Data / Form D filings / ZETAGEN THERAPEUTICS, INC.
ZETAGEN THERAPEUTICS, INC.: Form D filings
ZETAGEN THERAPEUTICS, INC., a pharmaceuticals company in Syracuse, NY, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on November 12, 2025, reports $12.9 million sold of a $13 million offering to 35 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 841 EAST FAYETTE STREET, Syracuse, NY, 13210
- Phone
- (315) 475-2200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1730728
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Amendment | $12,999,998 | $12,908,022 | $91,976 | 35 | Oct 31, 2025 | sec.gov |
| Jan 23, 2025 | New notice | $6,173,828 | $83,186 | $6,090,642 | 1 | Jan 21, 2025 | sec.gov |
| Feb 6, 2023 | New notice | $15,000,000 | $9,634,360 | $5,365,640 | 44 | Apr 29, 2022 | sec.gov |
| Dec 27, 2019 | New notice | $8,500,000 | $840,000 | $7,660,000 | 4 | Dec 13, 2019 | sec.gov |
| Dec 26, 2018 | New notice | $1,000,000 | $1,000,000 | 30 | Jul 13, 2018 | sec.gov | |
| Feb 13, 2018 | New notice | $1,726,000 | $1,726,000 | 47 | Jan 28, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joe C Loy | Executive Officer, Director | |
| Richard C Warburg | Director | |
| Ashok C Kaveeshwar | Director | |
| Peter B. Finn | Executive Officer | |
| Nikhil Thakur, MD | Executive Officer, Director | |
| Donald C Brown | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ZETAGEN THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.